MANAGEMENT AND COST ANALYSIS OF CANCER PATIENTS TREATED WITH G-CSF: A COHORT STUDY BASED ON THE FRENCH NATIONAL HEALTHCARE INSURANCE DATABASE (ECHANTILLON GENERALISTE DES BENEFICIAIRES)

被引:0
|
作者
Tilleul, P. [1 ]
Jacot, W. [2 ]
Emery, C. [3 ]
Lafuma, A. [4 ]
Gourmelen [5 ]
Fabre, N. [6 ]
Gaudin, H. [6 ]
机构
[1] Nantes Hosp Univ, Nantes, France
[2] Inst Reg Canc Montpellier, Montpellier, France
[3] Cemka, Bourg La Reine, France
[4] Cemka Eval, Bourg La Reine, France
[5] UVSQ, INSERM, UMS 011, Villejuif, France
[6] Chugai Pharma France, Puteaux La Defense, France
关键词
D O I
10.1016/j.jval.2017.08.365
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN282
引用
收藏
页码:A463 / A463
页数:1
相关论文
共 31 条
  • [31] Clinical predictors of failure of granulocyte colony stimulating factor (G-CSF) prophylaxis in patients with breast cancer treated with dose dense epirubicin (E), cyclophosphomide (C) plus paclitaxel (T) Adjuvant chemotherapy: Subgroup analysis of the NCIC CTG MA.21 study (NCT00014222)
    Ramjeesingh, Ravi
    Kankesan, Janarthanan
    Chen, Bingshu E.
    Pater, Joseph L.
    Han, Lei
    O'Brien, Patti
    Burnell, Margot J.
    Shepherd, Lois E.
    Parulekar, Wendy R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)